9/22/2020GNC Sale to Harbin Pharma Blessed by Court

9/22/2020I-Mab Cleared in China for P1 Trial of Lemzoparlimab in Relapsed or Re...

9/21/2020CDE Solicits Comments on the Technical Requirements for Pharmaceutical...

9/18/2020WiCON Publishes the China Pharmaceutical Guide 2020 (15th Edition)

9/18/2020MorphoSys and I-Mab Cleared by FDA for IND of Anticancer MOR210/TJ21...

9/18/2020REMD In-licenses Bispecific Antibody from GenScript ProBio

9/18/2020Recent Executive Moves

9/18/2020NHSA Publicizes the List of Drugs Passing Form Evaluation for Inclusio...

9/16/2020Croma and CNBG Form New Aesthetic Medicine JV in China

9/16/2020J&J Granted Clinical Trial Approvals for Amivantamab and Lazertinib in...

9/16/2020NMPA Suspends Import, Sales and Use of Polichem's Nifuratel

9/16/2020Genetron Health and dMed Announce Partnership for New Drug R&D Service

9/15/2020China Grants Priority Review Status to Roche's NDAs for Hemlibra Injec...

9/15/2020CDE Issues Document on Re-registration of Foreign-made Drug Products

9/15/2020Everest Reports on P1 Trial of Taniborbactam in Combo with Cefepime in...

9/15/2020With U.S.-China Relations Tremulous, Is China Still a Good Place to Do...

9/14/2020NMPA and Chinese Customs Announce Two New Drug Import Destination Port...

9/14/2020China to Step Up Fight against Depression and Alzheimer's Disease

9/11/2020Recent Executive Moves

9/11/2020China Issues the Guidance Policy for Strengthening and Enhancing BMI E...

9/11/2020CDE Solicits Comments on the Draft Technical Guidelines for Drug Inter...

9/11/2020Vice Premier Calls for Deepened Reform of Centralized Drug and Medical...

9/10/2020CMAB and Laekna Enter Partnership for ICI Drug Candidate

9/10/2020US Senator Requests CFIUS Review of GNC Acquisition by Harbin Pharma

9/10/2020Junshi Receives FDA Breakthru Therapy Designation for Toripalimab for ...

9/10/2020SinoPharm and Gilead Enter Strategic Deal for HBV Drug Vemlidy in Chin...

9/10/2020CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...

9/10/2020Gannex and Galmed Expand Development Programs For NASH

9/9/2020China Debates Cutting US Access to Drugs as Hostilities Spike

9/9/2020SCMP: Chinese Biotech Remains Heated with Surging M&A and IPO Deal...

Page:110/360 Total number of articles:10791: [First][<<] [108] [109] [110] [111] [112] [>>] [End]